Shares of Omega Healthcare Investors Inc (NYSE:OHI) have been given an average rating of “Hold” by the eleven research firms that are presently covering the company, MarketBeat Ratings reports. Seven analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 1-year target price among analysts that have issued a report on the stock in the last year is $37.40.
Several analysts recently weighed in on OHI shares. Zacks Investment Research upgraded Omega Healthcare Investors from a “sell” rating to a “hold” rating in a research note on Wednesday, May 8th. Stifel Nicolaus downgraded Omega Healthcare Investors from a “buy” rating to a “hold” rating and set a $39.00 price target on the stock. in a research note on Thursday, February 7th. ValuEngine downgraded Omega Healthcare Investors from a “buy” rating to a “hold” rating in a research note on Wednesday, April 3rd. Finally, Scotiabank started coverage on Omega Healthcare Investors in a research note on Thursday, February 7th. They issued a “sector perform” rating and a $39.37 price target on the stock.
In other Omega Healthcare Investors news, CFO Robert O. Stephenson sold 10,000 shares of the stock in a transaction on Monday, May 13th. The stock was sold at an average price of $37.00, for a total transaction of $370,000.00. Following the sale, the chief financial officer now directly owns 233,326 shares in the company, valued at approximately $8,633,062. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Ben W. Perks sold 3,000 shares of the stock in a transaction on Tuesday, March 26th. The shares were sold at an average price of $37.64, for a total value of $112,920.00. The disclosure for this sale can be found here. Insiders sold a total of 75,788 shares of company stock worth $2,810,176 in the last 90 days. 1.65% of the stock is currently owned by company insiders.
Shares of NYSE:OHI opened at $37.44 on Monday. Omega Healthcare Investors has a 52-week low of $28.10 and a 52-week high of $40.30. The company has a market capitalization of $7.75 billion, a PE ratio of 12.32, a PEG ratio of 4.92 and a beta of 0.46. The company has a debt-to-equity ratio of 1.16, a current ratio of 2.86 and a quick ratio of 2.86.
Omega Healthcare Investors (NYSE:OHI) last posted its quarterly earnings results on Tuesday, May 7th. The real estate investment trust reported $0.34 earnings per share for the quarter, missing the consensus estimate of $0.71 by ($0.37). The company had revenue of $188.20 million during the quarter, compared to analysts’ expectations of $190.54 million. Omega Healthcare Investors had a return on equity of 7.02% and a net margin of 30.17%. The business’s quarterly revenue was down 2.9% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.78 EPS. Equities research analysts forecast that Omega Healthcare Investors will post 2.99 EPS for the current year.
The business also recently declared a quarterly dividend, which was paid on Wednesday, May 15th. Investors of record on Tuesday, April 30th were paid a $0.66 dividend. The ex-dividend date was Monday, April 29th. This represents a $2.64 annualized dividend and a dividend yield of 7.05%. Omega Healthcare Investors’s payout ratio is currently 86.84%.
About Omega Healthcare Investors
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.